[1] Fleming A, Benn RT, Corbett M, et al. Early rheumatoid
disease, II: Patterns of joint involvement [J]. Ann
Rheum Dis, 1976(35):361-364.
[2] 张学军. 皮肤性病学[M].5 版. 北京:人民卫生出版社,2001:117-
118.
[3] Taylor W, Gladman D, Helliwell P, et al. Classification
criteria for psoriatic arthritis:Development of new criteria
from a large international study [J]. Arthritis Rheum, 2006
(54):2665-2673.
[4] Pedersen OB, Junker P. On the applicability of the CASPAR
criteria in psoriatic arthritis [J]. Ann Rheum Dis, 2008
(67):1495-1496.
[5] Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid
arthritis classification criteria: an American College of
Rheumatology/European League against Rheumatism collaborative
initiative [J]. Ann Rheum Dis, 2010(69):1580.
[6] Rahman P, Gladman DD, Cook RJ, et al. The use of
sulfasalazine in psoriatic arthritis: A clinic experience [J]. J
Rheumatol, 1998(25):1957.
[7] Abu- Shakra M, Gladman DD, Thorne JC, et al. Longterm
methotrexate therapy in psoriatic arthritis: Clinical and
radiologic outcome [J]. J Rheumatol,1995(22):241-245.
[8] Lee JCT, Gladman DD, Schentag CT, et al. The longterm
use of azathioprine in patients with psoriatic arthritis
[J]. J Clin Rheumatol, 2001(7):160-165.